Analytical chemistry

Accurate Detection of Small RNA Molecules in Individual Tumor Cell Particles Using CRISPR and Nanoflow Cytometry

Updated

Abstract

Detection limits for prostate cancer-associated microRNAs in tumor-derived extracellular vesicles are as low as 14.7 particles/mL.

  • A CRISPR/Cas13a-based platform enables ultrasensitive detection of microRNAs at the single particle level.
  • Tumor-derived extracellular vesicles were identified using specific aptamers against CD63 and EpCAM markers.
  • The method utilizes a novel membrane fusion strategy to reduce interference from non-target vesicles.
  • In plasma samples, prostate cancer patients showed significantly higher microRNA signals compared to healthy donors.
  • Receiver operating characteristic (ROC) analysis demonstrated strong diagnostic performance with AUC values above 0.869.
  • Multivariate analysis achieved a diagnostic accuracy of 91.3% for distinguishing between patient groups.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free